Core Insights - Visionary Holdings Inc. has appointed Ms. Wenxuan Cai as the CEO of its subsidiary, Visionary Health Technology Group Limited in Hong Kong, effective immediately [1] - The company has established a new wholly owned subsidiary in Nanjing, China, focusing on sales execution and market development, marking a shift from strategic positioning to active revenue generation [2] Leadership and Market Strategy - Ms. Cai brings nearly two decades of experience in market expansion and sales organization building, particularly in the healthcare sector, and will focus on enhancing sales infrastructure and execution [3][8] - The Nanjing entity will serve as a frontline commercial platform for regional sales operations, completing a fully integrated commercial structure alongside the Hong Kong platform [4] Commercialization Efforts - The company has transitioned from conceptual planning to operational commercialization, with a strong emphasis on building high-performance sales teams and translating market strategies into commercial results [5][6] - Recent milestones include strategic entry into cellular rejuvenation and aesthetic treatment markets, completion of global technology licensing, and the launch of a diversified product portfolio [9] Growth Potential - With leadership, products, and sales infrastructure aligned, the company is well-positioned to capitalize on the growing demand for advanced cellular-based and aesthetic solutions across Asia [7]